A Tool to Change Human Antigen R Protein Expression: May Have Implications in Ovarian Cancer & Diabetes >

 

Copyright © 2014 by Dr. Kerry Masterson  ·  All Rights reserved  ·  E-Mail: km@humanantigenr.com
 
 

  HuR: A Cancer and Diabetes Target          HuR mRNA Protective Sequence (HPS)           HPS Experiment Results          Contact
Human Antigen R mRNA Protective Sequence Site
 
PubMed search for HuR AND Ovarian Cancer


1: Prislei S, Martinelli E, Mariani M, Raspaglio G, Sieber S, Ferrandina G, Shahabi S, Scambia G, Ferlini C.
MiR-200c and HuR in ovarian cancer. BMC Cancer. 2013 Feb 8;13:72. doi: 10.1186/1471-2407-13-72. PubMed PMID: 23394580; PubMed Central PMCID: PMC3576328.

2: Raspaglio G, De Maria I, Filippetti F, Martinelli E, Zannoni GF, Prislei S,Ferrandina G, Shahabi S, Scambia G, Ferlini C.
HuR regulates beta-tubulin isotype expression in ovarian cancer.
Cancer Res. 2010 Jul 15;70(14):5891-900. doi:10.1158/0008-5472.CAN-09-4656. Epub 2010 Jun 29.                            PubMed PMID: 20587520.

3: Yi X, Zhou Y, Zheng W, Chambers SK.
HuR expression in the nucleus correlates with high histological grade and poor disease-free survival in ovarian cancer.
Aust N Z J Obstet Gynaecol. 2009 Feb;49(1):93-8. doi: 10.1111/j.1479-828X.2008.00937.x. PubMed PMID: 19281587.

4: Oyesanya RA, Lee ZP, Wu J, Chen J, Song Y, Mukherjee A, Dent P, Kordula T,Zhou H, Fang X.
Transcriptional and post-transcriptional mechanisms for lysophosphatidic acid-induced cyclooxygenase-2 expression in ovarian cancer cells. FASEB J. 2008 Aug;22(8):2639-51. doi: 10.1096/fj.07-101428. Epub 2008 Mar
24. PubMed PMID: 18362203; PubMed Central PMCID: PMC2493458.

5: Heinonen M, Fagerholm R, Aaltonen K, Kilpivaara O, Aittomäki K, Blomqvist C,Heikkilä P, Haglund C, Nevanlinna H, Ristimäki A. Prognostic role of HuR in hereditary breast cancer. Clin Cancer Res. 2007 Dec 1;13(23):6959-63. PubMed PMID: 18056170.

6: Lu Z, Luo RZ, Peng H, Rosen DG, Atkinson EN, Warneke C, Huang M, Nishmoto A, Liu J, Liao WS, Yu Y, Bast RC Jr. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian
cancer. Clin Cancer Res. 2006 Apr 15;12(8):2404-13. PubMed PMID: 16638845.

7: Erkinheimo TL, Sivula A, Lassus H, Heinonen M, Furneaux H, Haglund C, Butzow R, Ristimäki A. Cytoplasmic HuR expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian
carcinoma. Gynecol Oncol. 2005 Oct;99(1):14-9. PubMed PMID: 16126263.

8: Erkinheimo TL, Lassus H, Sivula A, Sengupta S, Furneaux H, Hla T, Haglund C, Butzow R, Ristimäki A. Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. Cancer Res.
2003 Nov 15;63(22):7591-4. PubMed PMID: 14633672.